Evidence map›Paper›PMID 31249676›Full record

ReviewF1000Research2019

A renewed tool kit to explore

Lee Dolat, Raphael H Valdivia

Open access · goldAbstract readReview
In one paragraph

Review in F1000Research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 27 citations in OpenAlex.

  1. Study Models forMicroorganisms · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Better In Vitro Tools for ExploringLife (Basel, Switzerland) · 2022
    Article
  6. Frontiers in cellular and infection microbiology · 2022
    Review
  7. Host-Pathogen Interactions ofPathogens (Basel, Switzerland) · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Murine Endometrial Organoids to ModelFrontiers in cellular and infection microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Lee DolatDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, USA.
Raphael H ValdiviaDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, USA.ORCID 0000-0003-0961-073X
Duke University · US

Funding

Functional characterization of early Chlamydia effectorsR01AI134891 · NIAID · DUKE UNIVERSITY · PI VALDIVIA, RAPHAEL H · 2018 to 2022
$2.4M
Data commons for 'omic, microscopy and analysis core facilitiesS10OD018164 · OD · DUKE UNIVERSITY · PI WRAY, GREGORY A. · 2014 to 2014
$598k
Subversion of the host cell cytoskeleton and innate immunity by Chlamydia trachomatisF32AI138372 · NIAID · DUKE UNIVERSITY · PI DOLAT, LEE · 2019 to 2021
$235k
NIAID NIH HHS F32 AI138372NIAID NIH HHS R01 AI134891NIH HHS S10 OD018164
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsChlamydia InfectionsChlamydia trachomatisDisease Models, AnimalEpithelial CellsFemaleHumansImmunity, InnateInfertilityIntercellular JunctionsPregnancycell-cell junctionsChlamydiageneticsinfection modelsorganoidspathogenesis

Identifiers

PMID31249676
PMCPMC6589931
OpenAlexW2951070448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.